A detailed history of Black Rock Inc. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 8,622,513 shares of RNA stock, worth $364 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,622,513
Previous 6,165,991 39.84%
Holding current value
$364 Million
Previous $157 Million 123.84%
% of portfolio
0.01%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$22.73 - $40.85 $55.8 Million - $100 Million
2,456,522 Added 39.84%
8,622,513 $352 Million
Q1 2024

May 10, 2024

SELL
$9.16 - $25.52 $3.03 Million - $8.44 Million
-330,602 Reduced 5.09%
6,165,991 $157 Million
Q4 2023

Feb 13, 2024

BUY
$4.87 - $9.37 $3.46 Million - $6.65 Million
710,018 Added 12.27%
6,496,593 $58.8 Million
Q3 2023

Nov 13, 2023

BUY
$6.3 - $11.35 $175,322 - $315,859
27,829 Added 0.48%
5,786,575 $36.9 Million
Q2 2023

Aug 11, 2023

BUY
$10.62 - $17.34 $1.33 Million - $2.17 Million
125,321 Added 2.22%
5,758,746 $63.9 Million
Q1 2023

May 12, 2023

BUY
$15.35 - $25.65 $5.33 Million - $8.91 Million
347,251 Added 6.57%
5,633,425 $86.5 Million
Q4 2022

Feb 13, 2023

BUY
$10.06 - $22.66 $11.7 Million - $26.4 Million
1,164,537 Added 28.25%
5,286,174 $117 Million
Q3 2022

Nov 14, 2022

BUY
$15.46 - $23.43 $2.94 Million - $4.45 Million
189,975 Added 4.83%
4,121,637 $67.3 Million
Q2 2022

Aug 12, 2022

BUY
$11.18 - $20.5 $7.44 Million - $13.6 Million
665,653 Added 20.38%
3,931,662 $57.1 Million
Q1 2022

May 12, 2022

SELL
$14.2 - $23.78 $446,888 - $748,380
-31,471 Reduced 0.95%
3,266,009 $60.3 Million
Q4 2021

Feb 10, 2022

BUY
$20.4 - $28.66 $1.73 Million - $2.43 Million
84,704 Added 2.64%
3,297,480 $78.4 Million
Q3 2021

Nov 09, 2021

BUY
$18.16 - $25.21 $9.31 Million - $12.9 Million
512,411 Added 18.98%
3,212,776 $79.1 Million
Q2 2021

Aug 11, 2021

BUY
$19.62 - $29.26 $53 Million - $79 Million
2,700,365 New
2,700,365 $66.7 Million

Others Institutions Holding RNA

About Avidity Biosciences, Inc.


  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $2.2B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.